30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Helen Torley

Track

Insider profile

Currently holds positions in Onyx Pharmaceuticals Inc, Quest Diagnostics Inc and Halozyme Therapeutics Inc

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 357%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Executive Vice President, Chief Commercial Officer Onyx Pharmaceuticals Inc Aug. 31, 2011 -
Independent Director Quest Diagnostics Inc Jan. 1, 2018 -
President, Chief Executive Officer, Director Halozyme Therapeutics Inc Jan. 6, 2014 -
Helen Torley's trades of Halozyme Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-03
PlS Planned sale
15,662 +49.2%
293.81
US$888,429 		15,662 +49.2% 293.81 US$888,429
2026-06-03 2026-06-03
PlS Planned sale
42,356 +15.7%
226.49
US$4,375,775 		42,356 +15.7% 226.49 US$4,375,775
2026-06-03 2026-06-03
PlS Planned sale
34,362 +37.7%
395.31
US$4,963,874 		34,362 +37.7% 395.31 US$4,963,874
2026-06-03 2026-06-03
PlS Planned sale
400 -0.1%
66.37
US$26,547 		400 -0.1% 66.37 US$26,547
2026-06-03 2026-06-02
PlS Planned sale
3,400 -0.4%
66.75
US$226,933 		3,400 -0.4% 66.75 US$226,933
2026-06-03 2026-06-02
PlS Planned sale
16,600 -2.1%
66.31
US$1,100,812 		16,600 -2.1% 66.31 US$1,100,812
2026-06-03 2026-06-01
PlS Planned sale
5,401 -0.7%
68.35
US$369,137 		5,401 -0.7% 68.35 US$369,137
2026-06-03 2026-06-01
PlS Planned sale
12,989 -1.7%
67.41
US$875,588 		12,989 -1.7% 67.41 US$875,588
2026-06-03 2026-06-01
PlS Planned sale
1,610 -0.2%
66.39
US$106,885 		1,610 -0.2% 66.39 US$106,885
2026-05-13 2026-05-13
PlS Planned sale
600 -0.1%
70.81
US$42,487 		600 -0.1% 70.81 US$42,487
2026-05-13 2026-05-13
PlS Planned sale
3,950 -0.5%
69.79
US$275,659 		3,950 -0.5% 69.79 US$275,659
2026-05-13 2026-05-13
PlS Planned sale
3,350 -0.4%
68.88
US$230,748 		3,350 -0.4% 68.88 US$230,748
2026-05-13 2026-05-13
PlS Planned sale
2,100 -0.3%
68.10
US$143,014 		2,100 -0.3% 68.10 US$143,014
2026-05-13 2026-05-12
PlS Planned sale
2,800 -0.4%
73.12
US$204,739 		2,800 -0.4% 73.12 US$204,739
2026-05-13 2026-05-12
PlS Planned sale
5,900 -0.8%
72.15
US$425,673 		5,900 -0.8% 72.15 US$425,673
2026-05-13 2026-05-12
PlS Planned sale
9,802 -1.2%
71.37
US$699,569 		9,802 -1.2% 71.37 US$699,569
2026-05-13 2026-05-12
PlS Planned sale
1,398 -0.2%
70.29
US$98,261 		1,398 -0.2% 70.29 US$98,261
2026-05-13 2026-05-12
PlS Planned sale
100 -0.0%
67.85
US$6,785 		100 -0.0% 67.85 US$6,785
2026-05-13 2026-05-11
PlS Planned sale
6,700 -0.9%
66.33
US$444,391 		6,700 -0.9% 66.33 US$444,391
2026-05-13 2026-05-11
PlS Planned sale
3,575 -0.5%
65.46
US$234,012 		3,575 -0.5% 65.46 US$234,012
2026-05-13 2026-05-11
PlS Planned sale
9,725 -1.2%
64.63
US$628,536 		9,725 -1.2% 64.63 US$628,536
2026-05-11 2026-05-11
PrS Proposed sale
101,923
64.12
US$6,535,303 		101,923 64.12 US$6,535,303
2026-04-07 2026-04-06
PlS Planned sale
4,100 -0.5%
64.02
US$262,462 		4,100 -0.5% 64.02 US$262,462
2026-04-07 2026-04-06
PlS Planned sale
5,900 -0.8%
63.14
US$372,520 		5,900 -0.8% 63.14 US$372,520
2026-04-02 2026-04-02
PlS Planned sale
4,200 -0.5%
64.89
US$272,525 		4,200 -0.5% 64.89 US$272,525
2026-04-02 2026-04-02
PlS Planned sale
4,200 -0.5%
64.89
US$272,525 		4,200 -0.5% 64.89 US$272,525
2026-04-02 2026-04-02
PlS Planned sale
15,800 -2.0%
64.06
US$1,012,195 		15,800 -2.0% 64.06 US$1,012,195
2026-04-02 2026-04-01
PlS Planned sale
1,000 -0.1%
65.71
US$65,714 		1,000 -0.1% 65.71 US$65,714
2026-04-02 2026-04-01
PlS Planned sale
1,000 -0.1%
65.71
US$65,714 		1,000 -0.1% 65.71 US$65,714
2026-04-02 2026-04-01
PlS Planned sale
19,000 -2.4%
65.36
US$1,241,802 		19,000 -2.4% 65.36 US$1,241,802
2026-04-02 2026-04-01
PlS Planned sale
19,000 -2.4%
65.36
US$1,241,802 		19,000 -2.4% 65.36 US$1,241,802
2026-03-04 2026-03-04
PlS Planned sale
2,671 -0.3%
70.95
US$189,494 		2,671 -0.3% 70.95 US$189,494
2026-03-04 2026-03-04
PlS Planned sale
7,329 -0.9%
69.94
US$512,620 		7,329 -0.9% 69.94 US$512,620
2026-03-04 2026-03-03
PlS Planned sale
6,519 -0.8%
69.33
US$451,982 		6,519 -0.8% 69.33 US$451,982
2026-03-04 2026-03-03
PlS Planned sale
13,481 -1.7%
68.85
US$928,167 		13,481 -1.7% 68.85 US$928,167
2026-03-04 2026-03-02
PlS Planned sale
578 -0.1%
70.46
US$40,726 		578 -0.1% 70.46 US$40,726
2026-03-04 2026-03-02
PlS Planned sale
15,322 -2.0%
69.80
US$1,069,460 		15,322 -2.0% 69.80 US$1,069,460
2026-03-04 2026-03-02
PlS Planned sale
4,100 -0.5%
69.20
US$283,708 		4,100 -0.5% 69.20 US$283,708
2026-02-05 2026-02-05
PlS Planned sale
4,624 -0.6%
78.94
US$365,000 		4,624 -0.6% 78.94 US$365,000
2026-02-05 2026-02-05
PlS Planned sale
5,376 -0.7%
78.38
US$421,366 		5,376 -0.7% 78.38 US$421,366
2026-02-05 2026-02-04
PlS Planned sale
10,100 -1.4%
77.54
US$783,154 		10,100 -1.4% 77.54 US$783,154
2026-02-05 2026-02-04
PlS Planned sale
9,900 -1.4%
76.94
US$761,666 		9,900 -1.4% 76.94 US$761,666
2026-02-05 2026-02-03
PlS Planned sale
7,790 -1.1%
76.73
US$597,758 		7,790 -1.1% 76.73 US$597,758
2026-02-05 2026-02-03
PlS Planned sale
9,659 -1.3%
75.94
US$733,543 		9,659 -1.3% 75.94 US$733,543
2026-02-05 2026-02-03
PlS Planned sale
2,551 -0.4%
74.88
US$191,016 		2,551 -0.4% 74.88 US$191,016